Evidence map›Paper›PMID 33222153›Full record

Trial reportBritish journal of haematology2021

COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.

Marquita Camilleri, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, Rakesh Popat, Karthik Ramasamy, Ceri Bygrave, Tushhar Dadaga and 8 more

Abstract readAdaptive Clinical TrialClinical Trial, Phase IILetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in British journal of haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marquita CamilleriHaematology Department, University College Hospitals, London, UK.ORCID 0000-0002-4161-8275
Jonathan SiveHaematology Department, University College Hospitals, London, UK.
William WilsonCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Gavin PangCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Richard JennerCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Elizabeth PhillipsDivision of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
Rakesh PopatHaematology Department, University College Hospitals, London, UK.ORCID 0000-0001-6553-4618
Karthik RamasamyHaematology Department, Oxford University Hospitals NHS Trust, Oxford, UK.
Ceri BygraveHaematology Department, University Hospital of Wales, Wales, UK.ORCID 0000-0002-1571-0692
Tushhar DadagaCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Matthew StreetlyHaematology Department, Guys and St Thomas' NHS Trust, London, UK.
James CavenaghHaematology Department, Bart's Health NHS Trust, London, UK.
Mike ChapmanHaematology Department, Cambridge Institute for Medical Research, Cambridge, UK.
Sally BarringtonSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.ORCID 0000-0002-2516-5288
Lucy PikeSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Roger OwenHMDS Laboratory, St James' Institute of Oncology, Leeds, UK.
Laura Clifton-HadleyCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Kwee YongHaematology Department, University College Hospitals, London, UK.ORCID 0000-0002-6487-276X

Funding

Cancer Research UK 24724Department of Health RP-2016-07-001Medical Research Council MC_UU_00025/10Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Stem Cell TransplantationCOVID-19CyclophosphamideDexamethasoneHumansMultiple MyelomaOligopeptidescarfilzomibCyclophosphamideDexamethasoneOligopeptidesclinical trialsCOVID-19myeloma

Identifiers

PMID33222153
PMCPMC7753290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.